Bal Pharma shines on getting certification for GMP compliance for manufacturing unit in Uttarakhand

05 Apr 2019 Evaluate

Bal Pharma is currently trading at Rs. 75.00, up by 5.50 points or 7.91% from its previous closing of Rs. 69.50 on the BSE.

The scrip opened at Rs. 72.10 and has touched a high and low of Rs. 76.80 and Rs. 72.10 respectively. So far 11627 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 109.00 on 11-Sep-2018 and a 52 week low of Rs. 62.75 on 18-Feb-2019.

Last one week high and low of the scrip stood at Rs. 76.80 and Rs. 68.70 respectively. The current market cap of the company is Rs. 105.73 crore.

The promoters holding in the company stood at 42.45%, while Institutions and Non-Institutions held 0.18% and 57.37% respectively.

Bal Pharma has received certification for GMP compliance for manufacturing unit located at Rudrapur in the state of Uttarakhand of formulations, as per European Union regulations. This EUGMP approval allows the plant to manufacture finished dosage formulations for supplying to regulated markets including Europe, US, Japan and Australia among others.

Bal Pharma is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Share Price

101.98 -1.09 (-1.06%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...